期刊文献+

艾塞那肽的合成 被引量:4

Synthesis of Exenatide
下载PDF
导出
摘要 艾塞那肽是胰高血糖素样肽-1(GLP-1)的类似物,由39个氨基酸组成,具有双激素靶向调控血糖的作用。该文对艾塞那肽的合成方法进行了研究,将原肽拆分成6个全保护片段,分别经过独立的固相或液相方法合成,然后对片段进行组装,经切割、纯化,得到艾塞那肽产品0.98 g,纯度﹥98%,总收率33.8%。切割时保留Fmoc-保护基可以使目标峰与杂峰有效分离。该方法结合了固相和液相合成的特点,与传统方法相比,是一种周期较短、纯化方便和收率较高的合成艾塞那肽的方法。 Exenatide, an analogue of glu residues and adjusts blood glucose level cagon-like peptide 1 ( GLP - 1 ), consists of 39 amino-acid through bidirectional hormone-targeted regulation. However, there are still many challenges about its synthetic methods. Herein, we split Exenatide into six fully protected peptide fragments and each fragment was synthesized by the solid-phase or liquid-phase method,respectively. After two-step cleavages and purifications, the final product of 0. 98 g (yield: 33.8% ,purity 〉 98% ) was obtained. The Fmoc-protective group attached to the Exenatide after the first step cleavage can enhance the separation of target from impurity efficiently in the purification step. The results show that this method, with the advantages of both solid-phase and liquid-phase syntheses, is a short-cycled, more convenient method and the yield is higher.
出处 《精细化工》 EI CAS CSCD 北大核心 2014年第10期1255-1261,共7页 Fine Chemicals
基金 国家自然科学基金资助项目(20872118 30070905) 陕西省重点实验室基金(2010JS097 11JS090 12JS110) 陕西省教育厅基金(12jk1010) 2013年西安市技术创新项目(CX13120)~~
关键词 艾塞那肽 片段肽 医药与日化原料 exenatide peptide fragments drug and cosmetic materials
  • 相关文献

参考文献8

  • 1Murphy C E. Review of the safety and efficacy of exenatide once weekly for the treatment of type 2 diabetes mellitus [ J ]. Ann Pharmacother, 2012,46 : 812 - 821.
  • 2Norris S L, Lee N, Thakurta S, et al. Exenatide efficacy and safety: a systematic review [ J ]. Diabet Med,2009,26 : 837 - 846.
  • 3Mikhail N. Exenatide : a novel approach for treatment of type 2 diabetes [ J ]. South Med J,2006,99 : 1271 - 1279.
  • 4Yoo B K, Triller D M, Yoo D J. Exenatide : a new option for the treatment of type 2 diabetes [ J ]. Ann Pharmacother, 2006,40 : 1777 - 1784.
  • 5Giannoukakis N. Exenatide. Amylin/Eli Lilly[ J J. Curt Opin in Investig Drugs,2003,4:459 - 465.
  • 6Walczak I M. Lilly and Amylin to collaborate on potential breakthrough diabetes treatment. [ J ]. Diabetes Technol Ther, 2002,4:738 -739.
  • 7韩香,王德心.多肽合成中“困难序列”的缩合研究进展(英文)[J].药学学报,2007,42(2):111-117. 被引量:12
  • 8Pasquale P, Dmitry A S. New TFA-Free cleavage and final deprotection in Fmoc Solid-Phase peptide synthesis : dilute HC1 in fluoroalcohol [ J ]. Org Lett,2012,14:6346 - 6349.

二级参考文献34

  • 1Teixido M,Albericio F,Giralt E.Solid-phase synthesis and characterization of N-methyl-rich peptides[J].J Pept Res,2005,65:153-166.
  • 2Bruckner H,Koza A.Solution phase synthesis of the 14-residue peptaibol antibiotic trichovirin Ⅰ[J].Amino Acids,2003,24:311-323.
  • 3Gatos D,Tzavara C.Comparison of the solid-phase fragment condensation and phase-change approaches in the synthesis of salmon I calcitonin[J].J Pept Res,2001,57:168-174.
  • 4Chan WC,White PD.Fmoc Solid Phase Peptide Synthesis--a Practical Approach[M].Oxford:Oxford University Press,2000:115-118.
  • 5Clippingdale AB,Macris M,Wade JD,et al.Synthesis and secondary structural studies of penta (acetyl-Hmb) A beta(1 -40)[J].JPept Res,1999,53:665-672.
  • 6Miranda LP,Meutermans WD,Smythe ML,et al.An activated O→ N acyl transfer auxiliary:efficient amidebackbone substitution of hindered "difficult" peptides[J].J Org Chem,2000,65:5460 -5468.
  • 7Meutermans WD,Bourne GT,Golding SW,et al.Difficult macrocyclizations:new strategies for synthesizing highly strained cyclic tetrapeptides[J].Org Lett,2003,5:2711 -2714.
  • 8May PJ,Bradley M,Harrowven DC,et al.A new method of forming resin bound thioesters and their use as'traceless' linkers in solid phase synthesis[J].Tetrahedron Lett,2000,41:1627-1630.
  • 9Bellanda M,Peggion E,Burgi R,et al.Conformational study of an Aib-rich peptide in DMSO by NMR[J].J Pept Res,2001,57:97-106.
  • 10Mutter M,Nefzi A,Sato T,et al.Pseudo-prolines (psi Pro) for accessing "inaccessible" peptides[J].J Pept Res,1995,8:145-153.

共引文献11

同被引文献30

  • 1南亚萍.片段法合成多肽的研究[J].化学与生物工程,2005,22(6):34-36. 被引量:4
  • 2张鸿鹏,甘一如.多肽液相分段合成及其进展[J].化学工业与工程,2006,23(3):254-259. 被引量:8
  • 3韩香,王德心.多肽合成中“困难序列”的缩合研究进展(英文)[J].药学学报,2007,42(2):111-117. 被引量:12
  • 4Valverde l E, Lecaille F, Lalmanach G, et al. Synthesis of a biologically active triazole-containing analogue of cystatin A through successive peptidomimetic alkyne-azide ligations[J]. Angew Chem Int Ed Engl, 2012,51(3):718-722.
  • 5Roberts M J, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation [J]. Adv Drug Dolly Rev, 2002, 54(4): 459-476.
  • 6Bertram A, Pattenden G, Marine metabolites: metalbinding and metal complexes of azole-based eyeliepeptides of ma- rine origin[J]. Nat Prod Rep, 2007, 24(1):18-30.
  • 7Wang T, Danishefsky SJ. Solid-phase peptide synthesis and solid-phase fragment coupling mediated by isonitriles[J]. PNAS, 2013, 110(29):11708-11713.
  • 8Mishra SK, Majumdar P, Behera RK, et al. Synthesis of 3- substiiuted pyrazole derivatives by mixed anhydride method and study of their antibacterial activities[J].Tylor Francis, 2014, 44(1):32-41.
  • 9Benon NL. Peptide synthesis: coupling methods[J].Chen Infarm, 2010, 41(12):1-9.
  • 10Lewis RJ, Dutertre S, Vetter I, et al. Conus. venom peptide pharmacology[J]. Pharmacol Rev, 2012, 64(2):259-298.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部